Among individuals without COVID-19 symptoms (Group A), the nasal SARS-CoV-2 WT-RBD IgA positivity rate was 88.4%, consistent with predictions of subclinical infection rates in China by Fu et al. This evidence concerns the gene CD79A and COVID-19.